Uricase from Candida sp., recombinant, expressed in E. coli, lyophilized powder, >=2 units/mg solid

Biochem/physiol Actions

Suitable for the determination of uric acid in clinical analysis.

General description

Uricase deficient mice develop uric acid nephropathy and diabetes insipidus which can be mitigated with recombinant uricase treatment.

Packaging

250, 1000 units in glass bottle

Physical form

Powder; contains citrate and sucrose

Unit Definition

One unit will oxidize 1.0 µmole of uric acid to allantoin per minute at pH 8.5 at 25 °C.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Quality Level InChI key InChI Manufacturer Storage Temp. Form Price
3581499 Uricase from Candida sp., recombinant, expressed in E. coli, lyophilized powder, >=2 units/mg solid 200 VPXDHZMLJOJKOX-UHFFFAOYSA-N 1S/C18H23N4O14P.H3N/c23-5-7-14(13(28)16(34-7)22-4-2-10(25)20-18(22)30)36-37(31,32)33-6-8-11(26)12(27)15(35-8)21-3-1-9(24)19-17(21)29;/h1-4,7-8,11-16,23,26-28H, SIGMA-ALDRICH −20°C lyophilized powder
3581500 Uricase from Candida sp., recombinant, expressed in E. coli, lyophilized powder, >=2 units/mg solid 200 VPXDHZMLJOJKOX-UHFFFAOYSA-N 1S/C18H23N4O14P.H3N/c23-5-7-14(13(28)16(34-7)22-4-2-10(25)20-18(22)30)36-37(31,32)33-6-8-11(26)12(27)15(35-8)21-3-1-9(24)19-17(21)29;/h1-4,7-8,11-16,23,26-28H, SIGMA-ALDRICH −20°C lyophilized powder
You need to be logged in to see prices.